mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-06 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-05 |